Edwards Lifesciences

EW · NYSE · USD

85,19 $Variazione rispetto alla chiusura precedente: −1,31%Variazione assoluta: −1,13 $

Chiusura · 1 ottobre 2026

Profilo dell'azienda

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Descrizione disponibile in inglese.

Dati societari

Settore
Salute
Industria
Medical Devices
Sede
One Edwards Way, 92614, Irvine
Dipendenti
16.000
Quotazione
EW · NYSE
Indici
S&P 500
Valuta
USD
Sito web
edwards.com